Tests an inhaler training device in older adults with chronic obstructive pulmonary disease
Tests a training device for inhaler technique in older adults with COPD.
Plain-language title generated from the registry record
Registry title: The Effectiveness of an Innovative Inhalation Training Device in Improving Medication Accuracy, Dyspnea, and Quality of Life in Elderly Patients With Chronic Obstructive Pulmonary Disease
Key facts
- Where
- Taipei, TaiwanSee the site
Where in Taiwan
- Taipei Veterans General HospitalTaipei, TaiwanNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Taipei Veterans General Hospital, Taiwan
- Trial code
- NCT07305649
- Record updated
- 26 December 2025
- Original description
This study aims to evaluate the effectiveness of an innovative inhaler training device, "Golden Rhino" (pMDI Practice Tool), in improving inhalation technique accuracy, dyspnea severity, and quality of life among elderly patients with chronic obstructive pulmonary disease (COPD). The device integrates a weighted valve and musical cues to guide patients in synchronizing their breath with proper pMDI inhalation technique. Participants will be randomly assigned to either standard nursing guidance or nursing guidance plus device-based training. Outcome measures include pMDI usage accuracy, dyspnea severity, and EQ-5D quality of life scores at baseline and follow-up.Read full original descriptionShow less
The Effectiveness of an Innovative Inhalation Training Device in Improving Medication Accuracy, Dyspnea, and Quality of Life in Elderly Patients With Chronic Obstructive Pulmonary Disease
This study aims to evaluate the effectiveness of an innovative inhaler training device, "Golden Rhino" (pMDI Practice Tool), in improving inhalation technique accuracy, dyspnea severity, and quality of life among elderly patients with chronic obstructive pulmonary disease (COPD). The device integrates a weighted valve and musical cues to guide patients in synchronizing their breath with proper pMDI inhalation technique. Participants will be randomly assigned to either standard nursing guidance or nursing guidance plus device-based training. Outcome measures include pMDI usage accuracy, dyspnea severity, and EQ-5D quality of life scores at baseline and follow-up.
Inclusion: Age ≥ 65 years old; Clinically diagnosed with Chronic Obstructive Pulmonary Disease (COPD) according to GOLD criteria; Currently using pressurized Metered Dose Inhaler (pMDI) medications; Ability to communicate and understand instructions in Mandarin or Taiwanese; Willing to participate and provide informed consent.
Exclusion: Concurrent enrollment in another interventional clinical trial; Diagnosis of severe cognitive impairment (e.g., dementia) that may interfere with participation; Severe visual or hearing impairment that may limit the ability to follow inhaler training instructions; Other diagnosed pulmonary diseases (e.g., lung cancer, pulmonary fibrosis) that may affect the assessment of COPD outcomes; Acute COPD exacerbation requiring hospitalization within the past 30 days.